In conclusion, this study presents a tumor‐targeted multifunctional nanotherapeutic platform (PPAPH) for the synergistic chemo‐phototherapy treatment of HER2‐positive breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.